CMPX vs CSX · $367.4M cap vs P/E 19, rev $14.09B
Compass Therapeutics Inc. (CMPX) versus CSX Corporation (CSX) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
CSX Corporation (CSX) is a railroads company listed on US.
CMPX does not have a complete income-statement cache yet.
Latest reported CSX revenue for 2025-12-31 was $14.09B. Net income was $2.89B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
CMPX currently screens at market cap $367.4M. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Not investment advice. Open the CMPX and CSX stock pages for the full models.
Not investment advice.